EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

7-Prenyloxycoumarins as Promising Antileishmanial Agents: In Vitro, In Vivo, and In Silico Evaluation Against Leishmania amazonensis

Dirlei Nico, Daniel Clemente de Moraes, Anna Claudia Silva, Igor Nunes Taveira iD, Yasmin da Silva Fontes iD, Rosangela Sabbatini Capella Lopes, Cláudio Cerqueira Lopes, Antonio Ferreira-Pereira iD

Pharmaceuticals · 05.03.2026 · 19 (3) · 426

DOI: 10.3390/ph19030426 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 05.03.2026. Verfasst von Dirlei Nico und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, …. Die Arbeit nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rio de Janeiro State Research Support Foundation- FAPERJ, National Council for Scientific and Technological Development- CNPq, Rio de Janeiro State Research Support Foundation-FAPERJ.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Leishmaniasis remains a major neglected tropical disease, and current chemotherapeutic options are limited by toxicity and resistance in Leishmania species, including L. amazonensis. Prenylated coumarins have emerged as promising bioactive scaffolds. Altissimacoumarin D and its analogues inhibit fungal efflux pumps associated with resistance. However, their antileishmanial potential and mechanisms of action remain unclear. Here, we evaluated the in vitro, in vivo, and in silico effects of altissimacoumarin D and seven analogues against L. amazonensis.

Methods

In vitro assays were performed to identify active compounds and assess toxicity in keratinocytes. In vivo experiments in hamsters evaluated antileishmanial activity and renal and hepatic toxicity. In silico analyses were conducted to investigate the mechanism of action of the substances.

Results

In vitro assays showed that ACS47, ACS48, and ACS51 were the most active and safe compounds. In a hamster infection model, daily administration of ACS47 and ACS48 (2.5 mg/kg) significantly reduced parasite burden and lesion size, while maintaining normal renal and hepatic biochemical parameters. Histological analysis correlated reduced lesion size with marked decreases in amastigote density. Based on in silico analysis, spermidine synthase was supported as a plausible molecular target.

Conclusions

Collectively, these findings identify ACS47 and ACS48 as promising lead compounds for future antileishmanial drug development.

Schlagwörter

Stichwörter der Autor:innen

Leishmaniaaltissimacoumarin Dantileishmanialcoumarinsspermidine synthase

Autor:innen und Institutionen

  • Departamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil.
  • Laboratório de Síntese e Análise de Produtos Estratégicos, Instituto de Química, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-909, RJ, Brazil.
  • Departamento de Microbiologia, Imunologia e Parasitologia, Faculdade de Ciências Médicas, Universidade do Estado do Rio de Janeiro, Rio de Janeiro 20550-170, RJ, Brazil.

ORCID-Profile: Igor Nunes Taveira, Yasmin da Silva Fontes, Antonio Ferreira-Pereira

Förderung

  • Rio de Janeiro State Research Support Foundation- FAPERJ
  • National Council for Scientific and Technological Development- CNPq
  • Rio de Janeiro State Research Support Foundation-FAPERJ
  • National Council for Scientific and Technological Development-CNPq

Zitieren

APA

Nico, D., de Moraes, D. C., Silva, A. C., Taveira, I. N., Fontes, Y. D. S., Lopes, R. S. C., Lopes, C. C., & Ferreira-Pereira, A. (2026). 7-Prenyloxycoumarins as Promising Antileishmanial Agents: In Vitro, In Vivo, and In Silico Evaluation Against Leishmania amazonensis. Pharmaceuticals, 19(3), 426. https://doi.org/10.3390/ph19030426

Vancouver

Nico D, de Moraes DC, Silva AC, Taveira IN, Fontes YDS, Lopes RSC, et al. 7-Prenyloxycoumarins as Promising Antileishmanial Agents: In Vitro, In Vivo, and In Silico Evaluation Against Leishmania amazonensis. Pharmaceuticals. 2026;19(3):426. doi:10.3390/ph19030426

BibTeX
@article{Nico2026,
  author = {Nico, Dirlei and de Moraes, Daniel Clemente and Silva, Anna Claudia and Taveira, Igor Nunes and Fontes, Yasmin da Silva and Lopes, Rosangela Sabbatini Capella and Lopes, Cláudio Cerqueira and Ferreira-Pereira, Antonio},
  title = {7-Prenyloxycoumarins as Promising Antileishmanial Agents: In Vitro, In Vivo, and In Silico Evaluation Against Leishmania amazonensis},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {3},
  pages = {426},
  doi = {10.3390/ph19030426}
}
Kostenlos starten →